Genetic screening before prescribing could benefit millions, study finds
pharmaphorum
JANUARY 29, 2021
“Our work shows the benefits that patients and the NHS could get from rolling out a national screening programme as part of their plans to embed pharmacogenomics in clinical practice by 2025, and that this testing could be effectively delivered by community pharmacists. Estimating the potential impact of implementing pre?emptive
Let's personalize your content